MyMD Pharmaceuticals, Inc. (MYMD)

NASDAQ: MYMD · IEX Real-Time Price · USD
2.390
+0.040 (1.70%)
At close: Mar 28, 2024, 4:00 PM
2.700
+0.310 (12.97%)
After-hours: Mar 28, 2024, 6:16 PM EDT

Total Valuation

MYMD has a market cap or net worth of $5.00 million. The enterprise value is -$3.38 million.

Market Cap 5.00M
Enterprise Value -3.38M

Important Dates

The next estimated earnings date is Monday, May 13, 2024, before market open.

Earnings Date May 13, 2024
Ex-Dividend Date n/a

Share Statistics

MYMD has 2.09 million shares outstanding. The number of shares has increased by 15.12% in one year.

Shares Outstanding 2.09M
Shares Change (YoY) +15.12%
Shares Change (QoQ) +11.39%
Owned by Insiders (%) 4.36%
Owned by Institutions (%) 10.42%
Float 1.52M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.32
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.71, with a Debt / Equity ratio of 0.01.

Current Ratio 1.71
Quick Ratio n/a
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -52.40% and return on invested capital (ROIC) is -97.86%.

Return on Equity (ROE) -52.40%
Return on Assets (ROA) -30.40%
Return on Capital (ROIC) -97.86%
Revenue Per Employee n/a
Profits Per Employee -$707,209
Employee Count 10
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -94.54% in the last 52 weeks. The beta is 3.26, so MYMD's price volatility has been higher than the market average.

Beta (1Y) 3.26
52-Week Price Change -94.54%
50-Day Moving Average 3.70
200-Day Moving Average 17.26
Relative Strength Index (RSI) 30.67
Average Volume (30 Days) 51,525

Short Selling Information

The latest short interest is 93,380, so 4.46% of the outstanding shares have been sold short.

Short Interest 93,380
Short Previous Month 92,705
Short % of Shares Out 4.46%
Short % of Float 6.16%
Short Ratio (days to cover) 2.20

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -15.26M
Pretax Income -5.38M
Net Income -7.07M
EBITDA -5.38M
EBIT -5.38M
Earnings Per Share (EPS) -$5.40
Full Income Statement

Balance Sheet

The company has $8.47 million in cash and $93,145 in debt, giving a net cash position of $8.38 million or $4.01 per share.

Cash & Cash Equivalents 8.47M
Total Debt 93,145
Net Cash 8.38M
Net Cash Per Share $4.01
Equity / Book Value 15.50M
Book Value Per Share 7.41
Working Capital 4.04M
Full Balance Sheet

Cash Flow

Operating Cash Flow -13.30M
Capital Expenditures n/a
Free Cash Flow -13.30M
FCF Per Share -$8.87
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MYMD does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -15.12%
Shareholder Yield -15.12%
Earnings Yield -141.47%
FCF Yield -265.98%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on February 15, 2024. It was a reverse split with a ratio of 1:30.

Last Split Date Feb 15, 2024
Split Type Reverse
Split Ratio 1:30

Scores

Altman Z-Score n/a
Piotroski F-Score 1